Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF.

Clin Infect Dis. 2011 Feb 1;52(3):285-92. doi: 10.1093/cid/cir034.

PMID:
21217178
2.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF; Infectious Diseases Society of America.

Clin Infect Dis. 2011 Feb 1;52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4. Erratum in: Clin Infect Dis. 2011 Aug 1;53(3):319.

PMID:
21208910
3.

Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.

Welsh KJ, Abbott AN, Lewis EM, Gardiner JM, Kruzel MC, Lewis CT, Mohr JF, Wanger A, Armitige LY.

J Clin Microbiol. 2010 Mar;48(3):894-9. doi: 10.1128/JCM.01949-09. Epub 2010 Jan 20.

4.

Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.

Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, Kim NJ, Kim EC, Oh MD, Choe KW.

Clin Infect Dis. 2009 Aug 1;49(3):395-401. doi: 10.1086/600295.

PMID:
19569970
6.
8.

Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.

Lewis T, Chaudhry R, Nightingale P, Lambert P, Das I.

Int J Infect Dis. 2011 Feb;15(2):e131-5. doi: 10.1016/j.ijid.2010.09.013. Epub 2010 Dec 4.

9.

[Clinical characteristics of methicillin-resistant Staphylococcus aureus in phlegm specimens].

Li GP, Zhou J, Wang A, Sun HL, Ma XJ, Xu YC.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Oct;30(5):531-4. Chinese.

10.

[Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].

Lepe JA, Gil-Navarro MV, Santos-Rubio MD, Bautista J, Aznar J.

Rev Esp Quimioter. 2010 Mar;23(1):43-7. Spanish.

11.

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP.

Clin Infect Dis. 2009 Aug 1;49(3):325-7. doi: 10.1086/600877. Erratum in: Clin Infect Dis. 2009 Nov 1;49(9):1465.

PMID:
19569969
12.

Diagnosis and management of community-associated MRSA infections in children.

Long CB, Madan RP, Herold BC.

Expert Rev Anti Infect Ther. 2010 Feb;8(2):183-95. doi: 10.1586/eri.09.127. Review.

PMID:
20109048
13.

Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.

Horne KC, Howden BP, Grabsch EA, Graham M, Ward PB, Xie S, Mayall BC, Johnson PD, Grayson ML.

Antimicrob Agents Chemother. 2009 Aug;53(8):3447-52. doi: 10.1128/AAC.01365-08. Epub 2009 Jun 8.

14.

Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.

Mongkolrattanothai K, Aldag JC, Mankin P, Gray BM.

BMC Infect Dis. 2009 Jul 16;9:112. doi: 10.1186/1471-2334-9-112.

15.

Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.

Barry A, McNicholas S, Smyth E, Humphreys H, Fitzpatrick F.

J Hosp Infect. 2010 Nov;76(3):272-3. doi: 10.1016/j.jhin.2010.03.003. No abstract available.

PMID:
20435374
16.

Severe invasive community-associated methicillin-resistant Staphylococcus aureus infections in previously healthy children.

Creel AM, Durham SH, Benner KW, Alten JA, Winkler MK.

Pediatr Crit Care Med. 2009 May;10(3):323-7. doi: 10.1097/PCC.0b013e3181988798.

PMID:
19307811
17.

A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice.

Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, Cornaglia G, Esposito S, French G, Giamarellou H, Gyssens IC, Nathwani D, Unal S, Voss A.

Clin Microbiol Infect. 2010 Mar;16 Suppl 1:3-30. doi: 10.1111/j.1469-0691.2010.03135.x. Review.

18.

Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized children: correlation of molecular analysis with clinical presentation and antibiotic susceptibility testing (ABST) results.

Abdel-Haq N, Al-Tatari H, Chearskul P, Salimnia H, Asmar BI, Fairfax MR, Amjad M.

Eur J Clin Microbiol Infect Dis. 2009 May;28(5):547-51. doi: 10.1007/s10096-008-0658-4. Epub 2008 Nov 20.

PMID:
19020911
19.

[Community onset of methicillin resistant Staphylococcus aureus infections in previously healthy or health care-associated children in Argentina].

Paganini H, Della MP, Muller B, Ezcurra G, Uranga M, Aguirre C, Kamiya M, Ensinck G, Miranda MR, Ciriaci C, Hernández C, Casimir L, Rial MJ, Schenonne N, Ronchi E, Rodríguez Mdel C, Aprile F, De Ricco C, Saito V, Vrátnica C, Pons L, Ernst A, Morinigo S, Toffoli M, Bosque C, Monzani V, Mónaco A, Pinheiro JL, López Mdel P, Maninno L, Sarkis C.

Rev Chilena Infectol. 2009 Oct;26(5):406-12. doi: /S0716-10182009000600002. Epub 2009 Nov 9. Spanish.

20.

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.

Yoon YK, Kim JY, Park DW, Sohn JW, Kim MJ.

J Antimicrob Chemother. 2010 May;65(5):1015-8. doi: 10.1093/jac/dkq050. Epub 2010 Mar 3.

PMID:
20200036

Supplemental Content

Support Center